Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:04 PM
Ignite Modification Date:
2025-12-26 @ 4:04 PM
NCT ID:
NCT02825706
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with hemophilia A or B
* Patients over 18 years
* Patients with hemophilic arthropathy with at least 1 involved joint (elbow, knee or ankle)
* having signed the informed consent document.
Exclusion Criteria:
* Patients diagnosed with other congenital bleeding disorders (i.e. von Willebrand disease)
* Patients who developed antibodies to FVIII or FIX (inhibitors)
* Those not able to ambulate as a result of hemophilic arthropathy or any other disability
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02825706
Study Brief:
Protocol Section:
NCT02825706